Surgery, Gastroenterology and Oncology
Vol. 20, No. 3, September 2015
A new score to predict outcome after liver transplantation
Speranţa Iacob, Liana Gheorghe, Daniela Tabacelia, Razvan Iacob, Cristian Gheorghe, Irinel Popescu
ORIGINAL PAPER, September 2015
Article DOI: 10.21614/jtmr-20-3-43
Background: An ideal liver allocation system should reduce waitlist mortality and also improve post-transplant survival.

Aim: To identify a new scoring system that predicts recipient survival at 3 months following liver transplantation (LT) in the Romanian program.

Methods: We included into analysis 242 adult patients (183 patients within the training set and 59 in the validation cohort) with liver cirrhosis consecutively transplanted between January 2012 and June 2014.

Results: Post-transplant overall survival was 84.2% at 3 months. Independent risk factors for survival following LT were: recipient age >53 years (p=0.01), serum albumin <2.7g dl (p=0.02), diabetes mellitus (p=0.14), hyponatremia <130mmol L, presence of non-malignant portal vein thrombosis (p=0.01), retransplantation (p=0.0005) and donor resuscitation following cardiac arrest (p=0.03). AUROC of RoSOFT score is 0.86 in both training and validation set. Diagnostic accuracy of RoSOFT for predicting 3 months mortality is 89.6%. Recipients with HCC outside Milan criteria had a significantly lower MELD score at LT compared to patients inside Milan (p=0.008) and received a higher proportion of marginal organs (p=0.005), but survival did not differ (p=0.47).

Conclusions: Combined recipient and donor risk factors can accurately predict 3-months survival following LT in our National LT Program and can be used to improve donorrecipient matching.

Keywords: liver transplantation, marginal donor, MELD, outcome, scoring system

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 1994


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Jun 2024

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/